Search for: "WATSON PHARMACEUTICALS "
Results 341 - 359
of 359
Sort by Relevance
|
Sort by Date
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid: (IPLaw360), … [read post]
4 Dec 2007, 9:28 pm
By Sherri Oslick -- Biovail Laboratories International SRL, a subsidiary of Biovail Corporation, and Watson Pharmaceuticals, Inc., have announced that they have reached a settlement agreement in Biovail's lawsuit against Andrx Pharmaceuticals, Inc., a subsidiary of Watson. [read post]
14 Nov 2007, 4:51 am
Defense attorneys moved to dismiss the class action against Watson Pharmaceuticals on the ground that it failed to plead fraud with the specificity required under the PSLRA; the district court granted the motion. [read post]
8 Nov 2007, 9:00 pm
Due to popular demand, I will have a separate section for Pharmaceutical Industry items from this week. [read post]
31 Oct 2007, 4:37 am
"Even so, Watson Chemical advertises that it makes active pharmaceutical ingredients. [read post]
17 Oct 2007, 10:00 pm
Reddy's Laboratories; Watson; Zambon andApotex. [read post]
26 Sep 2007, 1:04 pm
First, gabapentin must be highly purified before being formulated into the pharmaceutical preparation. [read post]
20 Sep 2007, 12:02 pm
Ortho Pharmaceutical Corp., 609 F. [read post]
20 Aug 2007, 12:04 am
Watson Pharmaceuticals, case no. 04-56791 (9th Cir. [read post]
26 May 2007, 11:26 pm
"...spokesmen [for BIO] declined to comment for this [Star-Ledger] story.'In terms of impact, the Star-Ledger identified the following issues:# Barr's Seasonale, the extended-cycle birth-control pill, faces generic competition from Watson Pharmaceuticals. [read post]
25 May 2007, 6:05 am
(the Howard Bashman of the medical world) has links to many more;Can we bring a state-based pharmaceutical case based on the drug's labeling, or does the drug company enjoy immunity because it was FDA approved? [read post]
27 Mar 2007, 11:29 pm
(One of those complaints was Beck complaining to Herrmann; the other was Herrmann complaining to Beck.)To make things easier, here's an index of all of our posts to date, with hyperlinks to the indexed materials:$3.7 million in fees for a $4000 recovery (Vioxx fee award) (6/23/07)Congressional preemption watch - good news (6/22/07)Informed consent and FDA regulatory status - oil and water still don't mix (6/21/07)The FDA bill - more on what Congress might do with preemption… [read post]
6 Mar 2007, 9:55 pm
By Donald Zuhn On Monday, Canadian pharmaceutical company Biovail (NYSE: BVF) announced that it had reached a comprehensive settlement with Anchen Pharmaceuticals, Impax Laboratories, Teva Pharmaceutical Industries, and Watson Pharmaceuticals with respect to Wellbutrin XL ® (bupropion HCl), a once-daily antidepressant which has a low incidence of sexual dysfunction, weight gain,... [read post]
1 Mar 2007, 4:57 am
The third generation oral contraceptives containing desogestrel are:Desogestrel and Ethinyl Estradiol (Duramed/Barr and Watson Pharmaceuticals)Desogen (Organon)Mircette (Duramed/Barr)Velivet (Duramed)Apri-28 (Duramed/Barr)Kariva (Duramed/Barr)Ortho-Cept (Ortho-McNeil)Reclipsen (Watson)Cyclessa (Organon)It is estimated that women in the U.S. filled more than 7.5 million prescriptions for third generation oral contraceptives this past year (November 2005 to October 2006)… [read post]
12 Feb 2007, 9:37 pm
The suit was filed in the Southern District of Florida in December 2005 by Andrx Pharmaceuticals, which was acquired by Watson last year. [read post]
24 Jan 2007, 9:59 pm
It was also recently reported that Lek D.D., a subsidiary of Sandoz, filed a complaint for patent infringement against Bristol-Myers Squibb and Watson Pharmaceuticals relating to BMS's Pravachol (pravastatin sodium). [read post]
5 Jan 2007, 9:49 pm
In response to the Federal Circuit's decision, Savient announced in a December 29 press release that Watson Pharmaceuticals has launched an A-B rated authorized generic of oxandrolone tablets. [read post]
19 Oct 2006, 3:46 pm
Meanwhile, Watson Pharmaceuticals is continuing to sell an authorized generic version of oxycodone. [read post]
16 Oct 2006, 7:58 pm
Solvay Pharmaceuticals settled patent litigation with generic drug makers Par Pharmaceutical Cos. and Watson Pharmaceuticals Inc. over Solvay's AndroGel drug product. [read post]
